PubRank

John D Allendorf

Author PubWeight™ 27.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas. Clin Cancer Res 2006 1.63
2 Incidence and predictors of bowel obstruction in elderly patients with stage IV colon cancer: a population-based cohort study. JAMA Surg 2013 1.57
3 BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas. Cancer Lett 2006 1.46
4 Laparoscopic distal pancreatectomy offers shorter hospital stays with fewer complications. J Gastrointest Surg 2010 1.28
5 Better preservation of endocrine function after central versus distal pancreatectomy for mid-gland lesions. Surgery 2010 1.10
6 Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas. J Gastrointest Surg 2009 1.04
7 RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer. J Gastrointest Surg 2011 1.00
8 Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res 2013 1.00
9 Bowel obstruction in elderly ovarian cancer patients: a population-based study. Gynecol Oncol 2012 0.99
10 Pancreaticoduodenectomy can be performed safely in patients aged 80 years and older. J Gastrointest Surg 2010 0.97
11 Predictive factors of malignancy in pediatric thyroid nodules. Surgery 2011 0.97
12 Readmission after pancreatic resection is not an appropriate measure of quality. Ann Surg Oncol 2012 0.96
13 One hundred thirty resections for pancreatic neuroendocrine tumor: evaluating the impact of minimally invasive and parenchyma-sparing techniques. J Gastrointest Surg 2010 0.96
14 Limitations of ACS-NSQIP in reporting complications for patients undergoing pancreatectomy: underscoring the need for a pancreas-specific module. World J Surg 2014 0.91
15 Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2008 0.89
16 Establishing a quantitative benchmark for morbidity in pancreatoduodenectomy using ACS-NSQIP, the Accordion Severity Grading System, and the Postoperative Morbidity Index. Ann Surg 2015 0.88
17 MRCP is not a cost-effective strategy in the management of silent common bile duct stones. J Gastrointest Surg 2013 0.87
18 RAGE signaling significantly impacts tumorigenesis and hepatic tumor growth in murine models of colorectal carcinoma. J Gastrointest Surg 2010 0.81
19 Revisiting metastatic adult pancreatoblastoma. A case and review of the literature. JOP 2008 0.81
20 Predictors of recurrence in intraductal papillary mucinous neoplasm: experience with 183 pancreatic resections. J Gastrointest Surg 2013 0.81
21 Quantitative X-ray computed tomography peritoneography in malignant peritoneal mesothelioma patients receiving intraperitoneal chemotherapy. Ann Surg Oncol 2013 0.80
22 Quantifying the burden of complications following total pancreatectomy using the postoperative morbidity index: a multi-institutional perspective. J Gastrointest Surg 2014 0.80
23 The management of aldosterone-producing adrenal adenomas--does adrenalectomy increase costs? Surgery 2010 0.80
24 Defining the post-operative morbidity index for distal pancreatectomy. HPB (Oxford) 2014 0.80
25 The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX. Surg Oncol Clin N Am 2004 0.79
26 Management and outcomes of bowel obstruction in patients with stage IV colon cancer: a population-based cohort study. Dis Colon Rectum 2013 0.79
27 The role of molecular analysis in the diagnosis and surveillance of pancreatic cystic neoplasms. JOP 2015 0.78
28 Routine intraoperative hepatic sonography does not affect staging or postsurgical hepatic recurrence in pancreatic adenocarcinoma. J Ultrasound Med 2014 0.77
29 Body surface area predicts plasma oxaliplatin and pharmacokinetic advantage in hyperthermic intraoperative intraperitoneal chemotherapy. Ann Surg Oncol 2013 0.76
30 Positron emission tomography (PET) has limited utility in the staging of pancreatic adenocarcinoma. J Gastrointest Surg 2014 0.76
31 A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage. Ann Surg 2017 0.75
32 An update on surgical staging of patients with pancreatic cancer. JOP 2012 0.75
33 Residency, fellowships, and pseudo fellowships: whither general surgery? Curr Surg 2005 0.75
34 Fine-needle aspirations of pancreatic serous cystadenomas: improving diagnostic yield with cell blocks and α-inhibin immunohistochemistry. Cancer Cytopathol 2013 0.75
35 Prophylactic pancreatectomy for intraductal papillary mucinous neoplasm does not negatively impact quality of life: a preliminary study. J Gastrointest Surg 2010 0.75
36 Short-term but not long-term loss of patency of venous reconstruction during pancreatic resection is associated with decreased survival. J Gastrointest Surg 2013 0.75
37 Progression of Incidental Intraductal Papillary Mucinous Neoplasms of the Pancreas in Liver Transplant Recipients. Pancreas 2016 0.75
38 Demographic features and natural history of intermediate-risk multifocal versus unifocal intraductal papillary mucinous neoplasms. Pancreas 2015 0.75
39 World wide what? The quality of information on parathyroid disease available on the Internet. Surgery 2009 0.75